Skip to main content
Log in

Clonidine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder

  • Clinical Trial Report
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry. 1991;48:324–8.

    PubMed  CAS  Google Scholar 

  2. Hunt RD, Capper L, O’Connell P. Clonidine in child and adolescent psychiatry. J Child Adolesc Psychopharmacol. 1990;1:87–102.

    Article  PubMed  CAS  Google Scholar 

  3. Prince J, Wilens T, Biederman J, et al. Clonidine for ADHD related sleep disturbances: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35:599–605.

    Article  PubMed  CAS  Google Scholar 

  4. Biederman J, Melmed RD, Patel A. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121:73–84.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mathew Nguyen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nguyen, M., White, K.A. & Bussing, R. Clonidine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder. Curr Psychiatry Rep 13, 313–315 (2011). https://doi.org/10.1007/s11920-011-0209-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-011-0209-z

Keywords

Navigation